ORPEA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.05 EUR | +0.76% |
|
+8.85% | -16.89% |
| Jun. 04 | ORPEA : Integrating the detailed FY23 figures |  |
| Jun. 04 | Emeis: sale of real estate assets in Ireland | CF |
| Sales 2024 * | 5.63B 6.13B | Sales 2025 * | 5.99B 6.52B | Capitalization | 2.24B 2.43B |
|---|---|---|---|---|---|
| Net income 2024 * | -292M -318M | Net income 2025 * | -175M -190M | EV / Sales 2024 * | 1.73 x |
| Net Debt 2024 * | 7.51B 8.17B | Net Debt 2025 * | 6.21B 6.75B | EV / Sales 2025 * | 1.41 x |
| P/E ratio 2024 * |
-0.01
x | P/E ratio 2025 * |
-0.02
x | Employees | 62,806 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.16% |
More Fundamentals
* Assessed data
More news
Latest transcript on ORPEA
More press releases
| 1 day | +0.76% | ||
| 1 week | +8.85% | ||
| Current month | +8.55% | ||
| 1 month | +5.37% | ||
| 3 months | +11.48% | ||
| 6 months | -14.35% | ||
| Current year | -16.89% |
1 week
12.09
14.16
1 month
12.0915.30
Current year
9.9718.10
1 year
9.972 800.00
3 years
9.97111 100.00
5 years
9.97129 000.00
10 years
9.97129 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Laurent Guillot
CEO | Chief Executive Officer | 54 | 22-06-30 |
Laurent Lemaire
DFI | Director of Finance/CFO | - | 21-12-07 |
| Chief Tech/Sci/R&D Officer | - | 22-10-09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 22-07-27 | |
Laurent Guillot
CEO | Chief Executive Officer | 54 | 22-06-30 |
Mireille Faugère
BRD | Director/Board Member | 66 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.13% | 17 M€ | +7.01% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-04 | 14.05 | +0.76% | 250,771 |
| 24-06-03 | 13.94 | +7.73% | 815,412 |
| 24-05-31 | 12.94 | +1.59% | 537,680 |
| 24-05-30 | 12.74 | +4.07% | 227,697 |
| 24-05-29 | 12.24 | -2.03% | 227,761 |
Real-time Euronext Paris, June 04, 2024 at 11:35 am EDT
More quotes
ORPEA is the European leader in global dependency care. The group operates retirement homes, follow-up care clinics, and psychiatric clinics. At the end of 2023, ORPEA had a network of 1,031 facilities (93,470 beds) located in France/Benelux/United Kingdom/Ireland (574 facilities; 45,431 beds), Central Europe (247; 24,316 beds), Eastern Europe (124; 12,764 beds), the Iberian Peninsula and Latin America (83; 10,394 beds), China (2; 154 beds) and the United Arab Emirates (1; 36 beds).
As of December 31st , 2023, the estimated value of the real estate portfolio was EUR 6.3 billion.
Net sales are distributed geographically as follows: France/Benelux/the United Kingdom/Ireland (58.4%), Central Europe (26%), Eastern Europe (9.9%), Iberian Peninsula and Latin America (5.5%) and other (0.2%).
Calendar
2024-06-25
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
14.05
EUR
Average target price
11,725
EUR
Spread / Average Target
+83,375.72%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.89% | 2.42B | |
| +15.30% | 1.63B | |
| +15.12% | 1.3B | |
| -30.52% | 1.23B | |
| +26.89% | 769M | |
| -12.73% | 434M | |
| +186.54% | 368M | |
| -10.85% | 326M | |
| +17.05% | 151M | |
| +24.52% | 81.28M |
- Stock Market
- Equities
- ORP Stock
